← Back to All US Stocks

CDIX Stock Analysis - Cardiff Lexington Corp AI Rating

CDIX OTC Services-Offices & Clinics of Doctors of Medicine FL CIK: 0000811222
Recently Updated • Analysis: Mar 22, 2026 • SEC Data: 2025-12-31
AI Rating
STRONG SELL
92% Confidence

📊 CDIX Key Takeaways

Revenue: $11.5M
Net Margin: -47.7%
Free Cash Flow: $-1.7M
Current Ratio: 0.87x
Debt/Equity: N/A
EPS: $-0.01
AI Rating: STRONG SELL with 92% confidence

Investment Thesis

Cardiff Lexington exhibits severe financial distress with negative stockholders' equity of -$2.5M, negative operating cash flow of -$1.7M, and a net loss of -$5.5M despite 39.5% revenue growth. The company is technically insolvent with liabilities exceeding assets and critically low liquidity (0.87x current ratio), indicating imminent financial crisis.

CDIX Strengths

  • + Strong revenue growth of 39.5% YoY demonstrates operational demand
  • + Solid gross margin of 62.5% indicates reasonable pricing power and cost control at gross profit level
  • + Adequate interest coverage ratio of 10.2x suggests current debt servicing capacity

CDIX Risks

  • ! Negative stockholders' equity of -$2.5M indicates technical insolvency and equity wipeout risk
  • ! Severe negative operating cash flow of -$1.7M despite positive gross profit signals fundamental operational cash generation problems
  • ! Critical liquidity crisis with only $318.5K cash against $26.0M total liabilities and 0.87x current ratio below 1.0x threshold
  • ! Net loss of -$5.5M and negative net margin of -47.7% despite gross profitability suggests SG&A and operating expenses are unsustainable
  • ! High long-term debt of $18.6M relative to total assets of $29.1M creates significant leverage risk

Key Metrics to Watch

CDIX Financial Metrics

Revenue
$11.5M
Net Income
$-5.5M
EPS (Diluted)
$-0.01
Free Cash Flow
$-1.7M
Total Assets
$29.1M
Cash Position
$318.5K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

CDIX Profitability Ratios

Gross Margin 62.5%
Operating Margin 9.5%
Net Margin -47.7%
ROE N/A
ROA -18.9%
FCF Margin -14.9%

CDIX vs Default Sector

How Cardiff Lexington Corp compares to Default sector averages

Net Margin
CDIX -47.7%
vs
Sector Avg 12.0%
CDIX Sector
ROE
CDIX 0.0%
vs
Sector Avg 15.0%
CDIX Sector
Current Ratio
CDIX 0.9x
vs
Sector Avg 1.8x
CDIX Sector
Debt/Equity
CDIX 0.0x
vs
Sector Avg 0.7x
CDIX Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CDIX Balance Sheet & Liquidity

Current Ratio
0.87x
Quick Ratio
0.87x
Debt/Equity
N/A
Debt/Assets
89.4%
Interest Coverage
10.24x
Long-term Debt
$18.6M

CDIX 5-Year Financial Trend

CDIX 5-year financial data: Year 2018: Revenue $2.4M, Net Income -$3.7M, EPS N/A. Year 2022: Revenue $12.0M, Net Income $666.3K, EPS $-0.01. Year 2023: Revenue $11.9M, Net Income -$5.4M, EPS N/A. Year 2024: Revenue $11.9M, Net Income $3.0M, EPS N/A. Year 2025: Revenue $11.5M, Net Income -$3.3M, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Cardiff Lexington Corp's revenue has grown significantly by 386% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.01 indicates the company is currently unprofitable.

CDIX Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-14.9%
Free cash flow / Revenue

CDIX Quarterly Performance

Quarterly financial performance data for Cardiff Lexington Corp including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $1.4M -$131.6K $-0.07
Q2 2025 $1.5M -$131.6K $-0.04
Q1 2025 $2.3M -$283.1K $-0.05
Q3 2024 $1.4M -$2.0M $-0.16
Q2 2024 $2.3M -$174.4K $-0.04
Q1 2024 $2.7M -$16.0K $-0.13
Q3 2023 $3.3M -$264.8K $0.00
Q2 2023 $3.1M -$61.8K $0.00

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

CDIX Capital Allocation

Operating Cash Flow
-$1.7M
Cash generated from operations
Dividends Paid
$50.0K
Returned to shareholders

CDIX SEC Filings

Access official SEC EDGAR filings for Cardiff Lexington Corp (CIK: 0000811222)

📋 Recent SEC Filings

Date Form Document Action
Mar 10, 2026 10-K cardiff_i10k-123125.htm View →
Feb 5, 2026 S-1/A cardiff_s1a3.htm View →
Feb 3, 2026 8-K cardiff_8k.htm View →
Feb 2, 2026 4 xslF345X05/ownership.xml View →
Jan 26, 2026 S-1/A cardiff_s1a2.htm View →

Frequently Asked Questions about CDIX

What is the AI rating for CDIX?

Cardiff Lexington Corp (CDIX) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CDIX's key strengths?

Strong revenue growth of 39.5% YoY demonstrates operational demand. Solid gross margin of 62.5% indicates reasonable pricing power and cost control at gross profit level.

What are the risks of investing in CDIX?

Negative stockholders' equity of -$2.5M indicates technical insolvency and equity wipeout risk. Severe negative operating cash flow of -$1.7M despite positive gross profit signals fundamental operational cash generation problems.

What is CDIX's revenue and growth?

Cardiff Lexington Corp reported revenue of $11.5M.

Does CDIX pay dividends?

Cardiff Lexington Corp pays dividends, with $0.1M distributed to shareholders in the trailing twelve months.

Where can I find CDIX SEC filings?

Official SEC filings for Cardiff Lexington Corp (CIK: 0000811222) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CDIX's EPS?

Cardiff Lexington Corp has a diluted EPS of $-0.01.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 22, 2026 | Data as of: 2025-12-31 | Powered by Claude AI